Synlait Milk (SML) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
9 Jul, 2026Executive summary
Returned to profitability in HY25 with net profit after tax of $4.8 million, reversing a prior loss, driven by strong Advanced Nutrition demand, operational improvements, and cost control.
EBITDA reached $63.1 million, up 217% year-over-year and slightly above guidance.
Revenue rose 16% year-over-year to $916.8 million, with gross profit up 99% to $87.0 million.
Net debt reduced by 29% to $391.9 million, mainly due to a major equity placement.
Operational focus on cost, quality, yield, and rebuilding farmer trust, with new CEO Richard Wyeth to start May 2025.
Financial highlights
EBITDA up $43.2 million year-over-year; NPAT improved by $101.0 million compared to prior period.
Gross profit per MT increased to $709, and return on net operating assets improved to 8.7%.
Operating cash flow improved by $86.1 million but remained negative at $(12.0) million due to higher advance payments to suppliers.
Net assets increased to $796.7 million from $698.9 million at 31 January 2024.
Basic and diluted EPS turned positive after several loss-making periods.
Outlook and guidance
FY25 full-year EBITDA expected to significantly improve over FY24, though second-half progress will be slower due to milk stream returns and FX risks.
Targeting closing net debt of $250–$300 million and net senior debt to EBITDA ratio below 2.5x for FY25.
Confident in milk supply for FY26, with most farmer suppliers remaining and new supplier interest exceeding expectations.
Directors acknowledge ongoing material uncertainty regarding access to capital until sustained improvement and sufficient withdrawal of cessation notices are confirmed.
Continued focus on operational efficiency, customer delivery, and value creation for customers.
Latest events from Synlait Milk
- Significant losses and deleveraging efforts defined the year, with recovery hinging on milk supply.SML
H2 20249 Jul 2026 - Net loss of $80.6 million, high debt, and asset sale drive a challenging but hopeful recovery.SML
H1 202616 Jun 2026 - North Island asset sale and record FY25 results drive strategic reset and debt reduction.SML
H2 202516 Jun 2026 - North Island asset sale to Abbott and debt reduction strategy mark a pivotal reset.SML
Investor presentation18 May 2026 - Major debt reduction, operational focus, and sustainability targets set for FY25.SML
Investor presentation18 May 2026 - Asset sale and board changes passed with over 99% approval, targeting debt reduction and growth.SML
AGM 20253 Feb 2026 - Major loss, balance sheet reset, and FY25 growth priorities with strong shareholder backing.SML
AGM 202412 Jan 2026